Sign inJoin waitlistJoin the waitlist

Jennifer Rymer

Associate Professor of Medicine · Duke University Hospital

Credentials: · · · · · · · · ·

History

Interventional Cardiology
Duke University Hospital
2019–2020
Cardiovascular Disease
Duke University Hospital
2014–2019
2015–2016
Internal Medicine
Duke University Hospital
2011–2014
Vanderbilt University School of Medicine
2007–2011
Vanderbilt University

Research

Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches
Annals of Surgery · 2008 · 313 citations
Prosthesis-Patient Mismatch in Patients Undergoing Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry
Journal of the American College of Cardiology · 2018 · 295 citations
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
Circulation · 2022 · 197 citations

William Jones
25 papers
Tracy Wang
22 papers
Manesh Patel
18 papers
Sunil Rao
18 papers
Eric Peterson
11 papers
Michael Nanna
11 papers · 1 as a fellow
Dennis Narcisse
10 papers
JG
Jorge Gutierrez
10 papers
Abdulla Damluji
9 papers
AK
Ajar Kochar
9 papers · 2 as a fellow
Dawn Abbott
9 papers
Pamela Douglas
9 papers

Grants

1/2 Low Dose Colchicine in pAtients with Peripheral Artery DiseasE to Assess Residual Vascular Risk (LEADER-PAD)
National Heart, Lung, and Blood Institute · UH3
PI · $3.7M · Duke University
2024–2029
Implementation of a Medication Adherence Instrument Among Patients with Symptomatic Peripheral Artery Disease After Peripheral Vascular Intervention
National Heart, Lung, and Blood Institute · K23
Contact PI · $331.3K · Duke University
2023–2028
1/2 Low Dose Colchicine in pAtients with Peripheral Artery DiseasE to Assess Residual Vascular Risk (LEADER-PAD)
National Heart, Lung, and Blood Institute · UG3
PI · $1.9M · Duke University
2024–2025

Clinical trials

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry
Principal investigator · Active not recruiting
Chiesi USA, Inc.
2019–2025
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Site PI · Recruiting · Phase 3
Population Health Research Institute
2021–2029